BOW

Bowhead Specialty Holdings Inc. - Q1 2026 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2026. Bowhead Specialty Holdings Inc. (Bowhead) is a Delaware-domiciled insurance holding company providing specialty commercial property and casualty insurance products in the U.S., primarily on a non-admitted (excess and surplus) basis. The company operates through a single segment with four underwriting divisions: Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. Bowhead maintains a strategic partnership with American Family Mutual Insurance Company (AmFam), which beneficially owns approximately 14.3% of the company's common stock.

Key Financial Metrics

Material Changes vs. Prior Period

• Premium Growth: Gross written premiums increased 24.0% to $216.7 million, driven by growth in the Casualty division ($25.0 million increase) and the Baleen Specialty division ($8.6 million increase). Net written premiums rose 20.2%.
• Profitability: Net income increased 40.1% to $16.0 million. The combined ratio improved by 2.0 points to 95.3%, primarily due to a 2.0 point reduction in the expense ratio (28.4% vs. 30.4%). The loss ratio remained flat at 66.9%.
• Investment Income: Net investment income surged 43.5% to $18.0 million, attributed to a higher average balance of investments.
• Debt Financing: Interest expense increased significantly to $3.2 million (from $0.2 million in Q1 2025) following the issuance of $150 million in 7.75% Senior Notes in November 2025.
• Comprehensive Income: Total comprehensive income was $7.5 million, lower than net income due to an $8.5 million unrealized loss on investments (net of tax), shifting the accumulated other comprehensive income to a loss position.

Outlook, Risks, and Unusual Items

• Capital Resources: The company holds $73.0 million in cash and investments at the holding company level. A new $35 million revolving credit facility (2025 Facility) was established in November 2025, replacing a terminated $75 million facility. No borrowings were outstanding under the new facility as of March 31, 2026.
• Subsequent Event: On May 4, 2026, Bowhead amended its Quota Share Agreement with AmFam to modify commercial terms, including premium caps and ceding fees. Management does not expect a material impact on financial statements.
• Reinsurance: The company cedes 26.0% of exposure via quota share and utilizes excess of loss treaties. All top reinsurers hold an "A" or better rating from A.M. Best. An allowance for credit losses on reinsurance recoverables was $0.2 million.
• Risks: Key risks include the inability to accurately assess underwriting risk, reliance on the strategic relationship with AmFam, reinsurer credit risk, and potential adverse outcomes from litigation or regulatory changes. The company is classified as an "emerging growth company."
• Unusual Items: There were no material non-operating expenses in Q1 2026, compared to $0.1 million in Q1 2025. Warrant expense remained consistent at $0.8 million.

Investor Verification Checklist

• AmFam Relationship: Verify the stability and terms of the strategic partnership with AmFam, given the recent amendment to the Quota Share Agreement and AmFam's 14.3% ownership stake.
• Reserve Adequacy: Review the sensitivity analysis for loss reserves, noting that a 7.5% increase in reserves would reduce pre-tax income by approximately $40 million for the Casualty division alone.
• Debt Servicing: Confirm the impact of the new $150 million Senior Notes (7.75% interest) on future cash flows and leverage ratios.
• Investment Portfolio: Assess the impact of interest rate fluctuations on the $1.52 billion fixed maturity portfolio, which currently holds a net unrealized loss position.
• Broker Concentration: Note that AmWINS Group and Ryan Specialty Group accounted for over 50% of gross written premiums combined.